Investors know that the key to profits is in the return – and that means, a willingness to shoulder risk. Risk is relative, …
CorMedix Inc. (NYSEAMERICAN:CRMD) investors are scratching their heads as to why the stock tanked today.
Roth Capital analyst Scott Henry came out yesterday with a research report on CorMedix Inc. (NYSEMKT:CRMD), maintaining a Neutral rating, while reducing the price …
CorMedix Inc. (NYSEMKT:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases, today …
CorMedix Inc (NYSE MKT:CRMD) insiders are prancing in the post parade as they prepare to enter the race of a lifetime. The apparent …